This purpose of this study is to investigate the effect of the self-regulation mode of continuous blood glucose monitoring on blood glucose indicators, self-efficacy, health-promoting behaviors, and medication compliance in patients with Type 2 diabetes. A prospective, randomized, double-blind experimental study is designed with 60 diabetic patients randomly assigned to the experimental group receiving continuous blood glucose monitoring and self-regulation mode of health education and the control group receiving self-monitoring of blood glucose and routine health education. Data will be collected three times, including blood glucose indicators and scales of self-efficacy, health promotion behaviors, and medication compliance.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Fasting blood glucose
Timeframe: Pre-test(baseline)
Fasting blood glucose
Timeframe: 7 days during intervention
Fasting blood glucose
Timeframe: 3 months after intervention
24-hr blood glucose
Timeframe: 7 days during intervention
HbA1C
Timeframe: Pre-test(baseline)
HbA1C
Timeframe: 3 months after intervention
Diabetes self-efficacy scale
Timeframe: Pre-test(baseline)
Diabetes self-efficacy scale
Timeframe: 8 days after intervention
Diabetes self-efficacy scale
Timeframe: 3 months after intervention
Diabetes health promoting behavior scale
Timeframe: Pre-test(baseline)
Diabetes health promoting behavior scale
Timeframe: 8 days after intervention
Diabetes health promoting behavior scale
Timeframe: 3 months after intervention
Medication compliance
Timeframe: Pre-test(baseline)
Medication compliance
Timeframe: 8 days after intervention
Medication compliance
Timeframe: 3 months after intervention